ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2019

Exacerbations, Health Resource Utilization, and Costs Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease Treated with Nebulized Arformoterol Following a Respiratory Event.

Maryam Navaie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.